Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.6192
Abstract: This post hoc analysis of 6 randomized, double-blind, placebo-controlled trials assesses the efficacy and safety of dupilumab in patients with erythrodermic atopic dermatitis. read more here.
Keywords: patients erythrodermic; erythrodermic atopic; dupilumab patients; efficacy safety ... See more keywords